FGI-103

Source: Wikipedia, the free encyclopedia.
FGI-103
Legal status
Legal status
Identifiers
  • 2-[(E)-2-(5-carbamimidoyl-1-benzofuran-2-yl)ethenyl]-3H-benzimidazole-5-carboximidamide
JSmol)
  • N=C(N)c4ccc3oc(C=Cc2nc1cc(C(=N)N)ccc1[nH]2)cc3c4
  • InChI=1S/C19H16N6O/c20-18(21)10-2-5-16-12(7-10)8-13(26-16)3-6-17-24-14-4-1-11(19(22)23)9-15(14)25-17/h1-9H,(H3,20,21)(H3,22,23)(H,24,25)/b6-3+
  • Key:OOKWWPFCCCMWIS-ZZXKWVIFSA-N

FGI-103 is an

Ebola virus and Marburg virus. In tests on mice FGI-103 was effective against both Ebola and Marburg viruses when administered up to 48 hours after infection. The mechanism of action of FGI-103 has however not yet been established, as it was found not to be acting by any of the known mechanisms used by similar antiviral drugs.[1][2][3]

See also

References

  1. PMID 20211898
    .
  2. PMID 23170168
    .
  3. PMID 25481298
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=FGI-103&oldid=1190246266"